AMT-116 in Patients with Solid Tumors

计划入组 144 人 · 首次发布于 2025 年 1 月 17 日

Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease

计划入组 12 人 · 首次发布于 2024 年 2 月 21 日

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

计划入组 20 人 · 首次发布于 2023 年 10 月 25 日

AMT-253

AMT-116

AMT-160

NMT Medical

Canada

Aethlon Medical

Vivani Medical

United States

AMT Medical Secures $25M Series B to Transform Coronary Bypass Surgery with Minimally Invasive Technology

AMT Medical's Sutureless ELANA Bypass System Meets Primary Endpoint in First Prospective CABG Trial

uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy